These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17618447

  • 1. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis.
    Anzic SA, Dzepina D, Kalogjera L.
    Eur Arch Otorhinolaryngol; 2007 Nov; 264(11):1309-14. PubMed ID: 17618447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP.
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [Abstract] [Full Text] [Related]

  • 4. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM.
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nasal obstruction improvement induced by topical furosemide in subjects affected by perennial nonallergic rhinitis.
    Masieri S, Cavaliere F, Filiaci F.
    Am J Rhinol; 1997 Sep; 11(6):443-7. PubMed ID: 9438057
    [Abstract] [Full Text] [Related]

  • 7. Effect of pre-treatment with inhaled furosemide on allergen nasal challenge.
    Nucera E, Schiavino D, Milani A, Patriarca G.
    Am J Rhinol; 1998 Sep; 12(5):359-61. PubMed ID: 9805537
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx.
    Pazdrak K, Górski P, Ruta U.
    Allergy; 1993 Nov; 48(8):598-601. PubMed ID: 7906926
    [Abstract] [Full Text] [Related]

  • 9. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C, Wagenmann M, Vossen-Holzenkamp S.
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [Abstract] [Full Text] [Related]

  • 10. The effect of levocabastine nasal spray in nasal provocation tests.
    Palma-Carlos AG, Palma-Carlos ML, Rombaut N.
    Int J Clin Pharmacol Res; 1988 Sep; 8(1):25-30. PubMed ID: 2896636
    [Abstract] [Full Text] [Related]

  • 11. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of threshold criteria for the nasal histamine challenge test in perennial allergic rhinitis.
    Kanthawatana S, Maturim W, Fooanant S, Manorot M, Trakultivakorn M.
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):65-9. PubMed ID: 9346268
    [Abstract] [Full Text] [Related]

  • 13. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA.
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
    [Abstract] [Full Text] [Related]

  • 14. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM, Vanden Bussche G.
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [Abstract] [Full Text] [Related]

  • 15. Acoustic rhinometry, rhinomanometry and the amount of nasal secretion in the clinical monitoring of the nasal provocation test.
    Pirilä T, Nuutinen J.
    Clin Exp Allergy; 1998 Apr; 28(4):468-77. PubMed ID: 9641574
    [Abstract] [Full Text] [Related]

  • 16. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
    Pécoud A, Zuber P, Kolly M.
    Int Arch Allergy Appl Immunol; 1987 Apr; 82(3-4):541-3. PubMed ID: 2883132
    [Abstract] [Full Text] [Related]

  • 17. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL, Goa KL.
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [Abstract] [Full Text] [Related]

  • 18. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S, Nielsen K, Bisgaard H, Mygind N.
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [Abstract] [Full Text] [Related]

  • 19. Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone.
    van de Heyning PH, van Haesendonck J, Creten W, Rombaut N.
    Allergy; 1988 Jul; 43(5):386-91. PubMed ID: 3046408
    [Abstract] [Full Text] [Related]

  • 20. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K, Pipkorn U, Bake B, Blychert LO.
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.